Logo Logo

Publications by Untch, M.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 12.

Journal article

Möbus, V.; Jackisch, C.; Luck, H. J.; du Bois, A.; Thomssen, C.; Kuhn, W.; Nitz, U.; Schneeweiss, A.; Huober, J.; Harbeck, N.; Minckwitz, G. von; Runnebaum, I. B.; Hinke, A.; Konecny, G. E.; Untch, M.; Kurbacher, C. (2018): Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial. In: Annals of Oncology, Vol. 29, No. 1: pp. 178-185

Mackelenberg, M. van; Denkert, C.; Nekljudova, V.; Karn, T.; Schem, C.; Marme, F.; Stickeler, E.; Jackisch, C.; Hanusch, C.; Huober, J.; Fasching, P.; Blohmer, J.-U.; Kummel, S.; Müller, V.; Schneeweiss, A.; Untch, M.; Minckwitz, G. von; Weber, K.; Loibl, S. (2017): Outcome after neoadjuvant chemotherapy in progesterone receptor negative breast cancer patients - A pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials. In: Cancer Research, Vol. 77

Hadji, P.; Coleman, R. E.; Wilson, C.; Powles, T. J.; Clezardin, P.; Aapro, M.; Costa, L.; Body, J.-J.; Markopoulos, C.; Santini, D.; Diel, I.; Di Leo, A.; Cameron, D.; Dodwell, D.; Smith, I.; Gnant, M.; Gray, R.; Harbeck, N.; Thurlimann, B.; Untch, M.; Cortes, J.; Martin, M.; Albert, U.-S.; Conte, P.-F.; Ejlertsen, B.; Bergh, J.; Kaufmann, M.; Holen, I. (2016): Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel. In: Annals of Oncology, Vol. 27, No. 3: pp. 379-390

Fasching, P. A.; Loibl, S.; Eidtmann, H.; Tesch, H.; Untch, M.; Hilfrich, J.; Schem, C.; Rezai, M.; Gerber, B.; Costa, S. D.; Blohmer, J. U.; Fehm, T. N.; Huober, J.; Liedtke, C.; Müller, V.; Nekljudova, V.; Weber, K.; Rack, B.; Rübner, M.; Wang, L.; Ingle, J. N.; Weinshilboum, R. M.; Minckwitz, G. von; Couch, F. (2016): BRCA mutations, therapy response and prognosis in the neoadjuvant GeparQuinto study. In: Cancer Research, Vol. 76

Untch, M.; Augustin, D.; Ettl, J.; Haidinger, R.; Harbeck, N.; Lück, H.-J.; Lüftner, D.; Marée, F.; Müller, L.; Overkamp, F.; Ruckhäberle, E.; Thill, M.; Thomssen, C.; Wuerstlein, R.; Marschner, N. (2016): ABC3 Consensus Commented from the Perspective of the German Guidelines Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07.11.2015. In: Geburtshilfe und Frauenheilkunde, Vol. 76, No. 2: pp. 156-163

Janning, M.; Müller, V; Vettorazzi, E.; Cubas-Cordova, M.; Gensch, V; Ben Batalla, I; Eulenburg, C. zu; Schem, C.; Fasching, P. A.; Schnappauf, B.; Karn, T.; Fehm, T.; Just, M.; Kühn, T.; Holms, F.; Overkamp, F.; Krabisch, P.; Rack, B.; Denkert, C.; Untch, M.; Tesch, H.; Rezai, M.; Kittel, K.; Pantel, K.; Bokemeyer, C.; Loibl, S.; Minckwitz, G. von; Loges, S. (2016): Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial. In: Oncology Research and Treatment, Vol. 39: p. 185

Lebeau, A.; Turzynski, A.; Braun, S.; Behrhof, W.; Fleige, B.; Schmitt, W. D.; Grob, T. J.; Burkhardt, L.; Hölzel, Dieter; Jackisch, C.; Thomssen, C.; Muller, V.; Untch, M. (2010): Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies. In: Journal of Clinical Oncology, Vol. 28, No. 20: pp. 3264-3270

Hermelink, K.; Henschel, Volkmar; Untch, M.; Bauerfeind, I.; Lux, M. P.; Munzel, K. (2008): Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study. In: Cancer, Vol. 113, No. 9: pp. 2431-2439

Stemmler, H. J.; Kahlert, S.; Siekiera, W.; Untch, M.; Heinrich, B.; Heinemann, Volker (2005): Prolonged survival of patients receiving trastuzumab beyond disease progression for HER2 overexpressing metastatic breast cancer (MBC). In: Onkologie, No. 11: pp. 582-586 [PDF, 97kB]

Tiling, R.; Keßler, M.; Untch, M.; Sommer, H.; Linke, R.; Brinkbäumer, K.; Hahn, K. (2003): Breast cancer: Monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography. In: Onkologie, No. 1: pp. 27-31 [PDF, 133kB]

Untch, M.; Crohns, C.; Kahlert, S.; Hepp, H. (2000): Anthrazykline und Herceptin® als neue Therapieoption beim metastasierten Mammakarzinom. In: Onkologie, No. 2: pp. 15-19 [PDF, 60kB]

Konecny, Gottfried; Frank, M.; Kahlert, S.; Untch, M.; Hepp, H. (2000): Retrospektive Analyse zur Dosisintensität von Epirubicin beim Mammakarzinom. In: Gynäkologisch-Geburtshilfliche Rundschau, No. 3-4: pp. 145-152 [PDF, 208kB]

This list was generated on Sun May 31 04:16:55 2020 CEST.